Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Cannabis Research Development

BTV-Business Television BTV-Business Television, www.b-tv.com
0 Comments| May 17, 2017

{{labelSign}}  Favorites
{{errorMessage}}


Beleave Inc. is awaiting clearance from Health Canada to begin cultivating their first crop and looking to lead next-generation discoveries in medical cannabis. Beleave Inc. ("Beleave" or the "Company") is a biotech company focused on the production of medical marijuana in Canada. The Company's wholly-owned subsidiary First Access Medical Inc. has applied for a license to cultivate and sell medical marijuana at its facility pursuant to the Access to Cannabis for Medical Purposes Regulations outlined by Health Canada. The Company is actively working towards the development of patents through research with Canadian institutions and the research and development of smoke harm reduction products. For more information on Beleave Inc. (BE.CN) please fill out the form below.
Symbol:C.BE


{{labelSign}}  Favorites
{{errorMessage}}